Erratum to: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries (CA: A Cancer Journal for Clinicians, (2018), 68, 6, (394-424), 10.3322/caac.21492);Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

CA Cancer Journal for Clinicians

Volumn 68, Issue 6, 2018, Pages 394-424

  Bray, Freddie ^a   Ferlay, Jacques ^a   Soerjomataram, Isabelle ^a   Siegel, Rebecca L ^b   Torre, Lindsey A ^b   Jemal, Ahmedin ^b  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b AMERICAN CANCER SOCIETY   (United States)

Author keywords

cancer; epidemiology; incidence; survival

Indexed keywords

ANUS CANCER; ARTICLE; BLADDER CANCER; BRAIN CANCER; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER RESEARCH; COLORECTAL CANCER; CUTANEOUS MELANOMA; ECONOMIC DEVELOPMENT; ESOPHAGUS CANCER; EVIDENCE BASED MEDICINE; GALLBLADDER CANCER; GEOGRAPHY; HODGKIN DISEASE; HUMAN; HYPOPHARYNX CANCER; KAPOSI SARCOMA; KIDNEY CANCER; LARYNX CANCER; LEUKEMIA; LIFESTYLE; LIVER CANCER; LUNG CANCER; MALIGNANT NEOPLASM; MESOTHELIOMA; MOUTH CANCER; MULTIPLE MYELOMA; NASOPHARYNX CANCER; NON MELANOMA SKIN CANCER; NONHODGKIN LYMPHOMA; OROPHARYNX CANCER; OVARY CANCER; PANCREAS CANCER; PENIS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; SALIVARY GLAND CANCER; SOCIAL ASPECT; STOMACH CANCER; TESTIS CANCER; THYROID CANCER; UTERINE CERVIX CANCER; UTERUS CANCER; VAGINA CANCER; VULVA CANCER; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CAUSE OF DEATH; CHILD; FEMALE; GLOBAL DISEASE BURDEN; GLOBAL HEALTH; INCIDENCE; INFANT; MALE; MIDDLE AGED; NEOPLASM; NEWBORN; PRESCHOOL CHILD; PREVALENCE; REGISTER; RISK FACTOR; SEX RATIO; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; TRENDS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; FEMALE; GLOBAL BURDEN OF DISEASE; GLOBAL HEALTH; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NEOPLASMS; PREVALENCE; REGISTRIES; RISK FACTORS; SEX DISTRIBUTION; SURVIVAL RATE; YOUNG ADULT;

EID: 85053395052     PISSN: 00079235     EISSN: 15424863     Source Type: Journal    
DOI: 10.3322/caac.21609     Document Type: Erratum

References (83)

1. World Health Organization. Global Health Observatory. Geneva: World Health Organization; 2018. who.int/gho/database/en/. Accessed June 21, 2018.
2. Omran AR. The epidemiologic transition. A theory of the epidemiology of population change. Milbank Mem Fund Q. 1971;49:509-538.
3. Gersten O, Wilmoth JR. The cancer transition in Japan since 1951. Demogr Res. 2002;7:271-306.
4. Bray F. Transitions in human development and the global cancer burden. In: Stewart BW, Wild CP, eds. World Cancer Report 2014. Lyon: IARC Press; 2014:42-55.
5. Maule M, Merletti F. Cancer transition and priorities for cancer control. Lancet Oncol. 2012;13:745-746.
6. Ferlay J, Colombet M, Soerjomataram I et al. Global and Regional Estimates of the Incidence and Mortality for 38 Cancers: GLOBOCAN 2018. Lyon: International Agency for Research on Cancer/World Health Organization; 2018.
7. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108.
8. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
9. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87-108.
10. United Nations Development Programme. Human Development Report 2016: Human Development for Everyone. New York, NY: United Nations Development Programme; 2016.
11. Hankey BF, Feuer EJ, Clegg LX, et al. Cancer surveillance series: interpreting trends in prostate cancer—Part I: evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. J Natl Cancer Inst. 1999;91:1017-1024.
12. Vaccarella S, Franceschi S, Bray F, Wild CP, Plummer M, Dal Maso L. Worldwide thyroid-cancer epidemic? The increasing impact of overdiagnosis. N Engl J Med. 2016;375:614-617.
13. Bray F, Colombet M, Mery L et al. Cancer Incidence in Five Continents, Vol. XI (electronic version). Lyon: International Agency for Research on Cancer; 2017. ci5.iarc.fr/Default.aspx. Accessed June 21, 2018.
14. Doll R, Payne P, Waterhouse J. Cancer Incidence in Five Continents: A Technical Report. New York: Springer; 1966.
15. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer. 2001;37(suppl 8):S4-S66.
16. Alonso R, Pineros M, Laversanne M, et al. Lung cancer incidence trends in Uruguay 1990–2014: an age-period-cohort analysis. Cancer Epidemiol. 2018;55:17-22.
17. Lortet-Tieulent J, Renteria E, Sharp L, et al. Convergence of decreasing male and increasing female incidence rates in major tobacco-related cancers in Europe in 1988–2010. Eur J Cancer. 2015;51:1144-1163.
18. Thun MJ, Henley SJ, Travis WD. Lung cancer. In: Thun MJ, Linet MS, Cerhan JR, Haiman CA, Schottenfeld D, eds. Cancer Epidemiology and Prevention. 4th ed. New York, NY: Oxford University Press; 2018:519-542.
19. Jemal A, Miller KD, Ma J, et al. Higher lung cancer incidence in young women than young men in the United States. N Engl J Med. 2018;378:1999-2009.
20. Jha P. Avoidable global cancer deaths and total deaths from smoking. Nat Rev Cancer. 2009;9:655-664.
21. Parkin DM, Bray F, Ferlay J, Jemal A. Cancer in Africa 2012. Cancer Epidemiol Biomarkers Prev. 2014;23:953-966.
22. Ferlay J, Bray F, Steliarova-Foucher E, Forman D. Cancer Incidence in Five Continents, CI5plus. IARC CancerBase No. 9. Lyon: International Agency for Research on Cancer; 2018. ci5.iarc.fr/CI5plus/default.aspx. Accessed June 21, 2018.
23. Ziegler RG, Hoover RN, Pike MC, et al. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst. 1993;85:1819-1827.
24. Brinton LA, Gaudet MM, Gierach GL. Breast cancer. In: Thun MJ, Linet MS, Cerhan JR, Haiman CA, Schottenfeld D, eds. Cancer Epidemiology and Prevention. 4th ed. New York: Oxford University Press; 2018:861-888.
25. Bray F, McCarron P, Parkin DM. The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res. 2004;6:229-239.
26. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002;288:321-333.
27. Ravdin PM, Cronin KA, Howlader N, et al. The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med. 2007;356:1670-1674.
28. Fidler MM, Soerjomataram I, Bray F. A global view on cancer incidence and national levels of the Human Development Index. Int J Cancer. 2016;139:2436-2446.
29. Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66:683-691.
30. Schreuders EH, Ruco A, Rabeneck L, et al. Colorectal cancer screening: a global overview of existing programmes. Gut. 2015;64:1637-1649.
31. Wu K, Keum N, Nishihara R, Giovannucci EL. Cancers of the colon and rectum. In: Thun MJ, Linet MS, Cerhan JR, Haiman CA, Schottenfeld D, eds. Cancer Epidemiology and Prevention. 4th ed. New York, NY: Oxford University Press; 2018:681-706.
32. World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR). Continuous Update Project Report: Diet, Nutrition, Physical Activity and Colorectal Cancer 2016. Revised 2018. London: World Cancer Research Fund International; 2018. aicr.org/continuous-update-project/reports/colorectal-cancer-2017-report.pdf. Accessed June 21, 2018.
33. Magalhaes B, Peleteiro B, Lunet N. Dietary patterns and colorectal cancer: systematic review and meta-analysis. Eur J Cancer Prev. 2012;21:15-23.
34. Rebbeck TR, Devesa SS, Chang BL, et al. Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of African descent [serial online]. Prostate Cancer. 2013;2013:560857.
35. Bray F, Kiemeney L. Epidemiology of prostate cancer in Europe: patterns, trends and determinants. In: Bolla M, van Poppel H, eds. Management of Prostate Cancer: A Multidisciplinary Approach. Berlin: Springer-Verlag; 2017:1-11.
36. Kvale R, Auvinen A, Adami HO, et al. Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries. J Natl Cancer Inst. 2007;99:1881-1887.
37. Zhou CK, Check DP, Lortet-Tieulent J, et al. Prostate cancer incidence in 43 populations worldwide: an analysis of time trends overall and by age group. Int J Cancer. 2016;138:1388-1400.
38. Center MM, Jemal A, Lortet-Tieulent J, et al. International variation in prostate cancer incidence and mortality rates. Eur Urol. 2012;61:1079-1092.
39. Grossman DC, Curry SJ, Owens DK, et al. Screening for prostate cancer: US Preventive Services Task Force recommendation statement. JAMA. 2018;319:1901-1913.
40. Kvale R, Myklebust TA, Engholm G, Heinavaara S, Wist E, Moller B. Prostate and breast cancer in four Nordic countries: a comparison of incidence and mortality trends across countries and age groups 1975–2013. Int J Cancer. 2017;141:2228-2242.
41. Bray F, Pineros M. Cancer patterns, trends and projections in Latin America and the Caribbean: a global context. Salud Publica Mex. 2016;58:104-117.
42. Wabinga HR, Nambooze S, Amulen PM, Okello C, Mbus L, Parkin DM. Trends in the incidence of cancer in Kampala, Uganda 1991–2010. Int J Cancer. 2014;135:432-439.
43. Chokunonga E, Borok MZ, Chirenje ZM, Nyakabau AM, Parkin DM. Trends in the incidence of cancer in the black population of Harare, Zimbabwe 1991–2010. Int J Cancer. 2013;133:721-729.
44. Wong MC, Goggins WB, Wang HH, et al. Global incidence and mortality for prostate cancer: analysis of temporal patterns and trends in 36 countries. Eur Urol. 2016;70:862-874.
45. Brawley OW. Trends in prostate cancer in the United States. J Natl Cancer Inst Monogr. 2012;2012:152-156.
46. Kolonel LN, Hankin JH, Nomura AMY. Multiethnic studies of diet, nutrition, and cancer in Hawaii. In: Hayashi Y, Nagao M, Sugimura T, et al, eds. Diet, Nutrition and Cancer. Proceedings of the 16th International Symposium of the Princess Takamatsu Cancer Research Fund; Tokyo, Japan; 1985. Tokyo: Japan Scientific Societies Press; Utrecht, the Netherlands: VNU Science Press BV; 1986:29-40.
47. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Infection with Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum. 1994;61:177-240.
48. Plummer M, Franceschi S, Vignat J, Forman D, de Martel C. Global burden of gastric cancer attributable to Helicobacter pylori. Int J Cancer. 2015;136:487-490.
49. World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR). Continuous Update Project Report: Diet, Nutrition, Physical Activity and Stomach Cancer 2016. Revised 2018. London: World Cancer Research Fund International; 2018. wcrf.org/sites/default/files/Stomach-Cancer-2016-Report.pdf. Accessed June 21, 2018.
50. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Personal habits and indoor combustions. Volume 100 E. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum. 2012;100(pt E):1-538.
51. Howson CP, Hiyama T, Wynder EL. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev. 1986;8:1-27.
52. deMartel C, Parsonnet J. Stomach cancer. In: Thun MJ, Linet MS, Cerhan JR, Haiman CA, Schottenfeld D, eds. Cancer Epidemiology and Prevention. 4th ed. New York: Oxford University Press; 2018:593-610.
53. London WT, Petrick JL, McGlynn KA. Liver cancer. In: Thun MJ, Linet MS, Cerhan JR, Haiman CA, Schottenfeld D, eds. Cancer Epidemiology and Prevention. 4th ed. New York: Oxford University Press; 2018:635-660.
54. Chimed T, Sandagdorj T, Znaor A, et al. Cancer incidence and cancer control in Mongolia: results from the National Cancer Registry 2008–12. Int J Cancer. 2017;140:302-309.
55. Marengo A, Rosso C, Bugianesi E. Liver cancer: connections with obesity, fatty liver, and cirrhosis. Annu Rev Med. 2016;67:103-117.
56. World Health Organization. Global Health Observatory (GHO) data: Hepatitis B 3rd Dose (HepB3) Immunization Coverage. Geneva: World Health Organization; 2017. who.int/gho/immunization/hepatitis/en/. Accessed February 27, 2018.
57. Chang MH, Chen CJ, Lai MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997;336:1855-1859.
58. Thursz M, Fontanet A. HCV transmission in industrialized countries and resource-constrained areas. Nat Rev Gastroenterol Hepatol. 2014;11:28-35.
59. Blot WJ, Tarone RE. Esophageal cancer. In: Thun MJ, Linet MS, Cerhan JR, Haiman CA, Schottenfeld D, eds. Cancer Epidemiology and Prevention. 4th ed. New York: Oxford University Press; 2018:579-592.
60. McCormack VA, Menya D, Munishi MO, et al. Informing etiologic research priorities for squamous cell esophageal cancer in Africa: a review of setting-specific exposures to known and putative risk factors. Int J Cancer. 2017;140:259-271.
61. Arnold M, Laversanne M, Brown LM, Devesa SS, Bray F. Predicting the future burden of esophageal cancer by histological subtype: international trends in incidence up to 2030. Am J Gastroenterol. 2017;112:1247-1255.
62. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12-19.
63. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum. 2007;90:1-636.
64. Herrero R, Murillo R. Cervical cancer. In: Thun MJ, Linet MS, Cerhan JR, Haiman CA, Schottenfeld D, eds. Cancer Epidemiology and Prevention. 4th ed. New York: Oxford University Press; 2018:925-946.
65. International Agency for Research on Cancer (IARC). IARC Handbooks of Cancer Prevention: Volume 10-Cervix Cancer Screening. Lyon: IARC Press; 2005. iarc.fr/en/publications/pdfs-online/prev/handbook10/HANDBOOK10.pdf. Accessed June 21, 2018.
66. Bray F, Carstensen B, Moller H, et al. Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Biomarkers Prev. 2005;14:2191-2199.
67. Bray F, Loos AH, McCarron P, et al. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Cancer Epidemiol Biomarkers Prev. 2005;14:677-686.
68. Bray F, Lortet-Tieulent J, Znaor A, Brotons M, Poljak M, Arbyn M. Patterns and trends in human papillomavirus-related diseases in central and eastern Europe and central Asia. Vaccine. 2013;31(suppl 7):H32-H45.
69. Vaccarella S, Laversanne M, Ferlay J, Bray F. Cervical cancer in Africa, Latin America and the Caribbean and Asia: regional inequalities and changing trends. Int J Cancer. 2017;141:1997-2001.
70. Ronco G, Dillner J, Elfstrom KM, et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet 2014;383:524-532.
71. Sankaranarayanan R. HPV vaccination: the most pragmatic cervical cancer primary prevention strategy. Int J Gynaecol Obstet. 2015;131(suppl 1):S33-S35.
72. Thun MJ, Wild CP, Colditz G. Framework for understanding cancer prevention. In: Thun MJ, Linet MS, Cerhan JR, Haiman CA, Schottenfeld D, eds. Cancer Epidemiology and Prevention. 4th ed. New York: Oxford University Press; 2018:1193-1204.
73. Bosch FX, Robles C, Diaz M, et al. HPV-FASTER: broadening the scope for prevention of HPV-related cancer. Nat Rev Clin Oncol. 2016;13:119-132.
74. Kitahara CM, Schneider AB, Brenner AV. Thyroid cancer. In: Thun MJ, Linet MS, Cerhan JR, Haiman CA, Schottenfeld D, eds. Cancer Epidemiology and Prevention. 4th ed. New York: Oxford University Press; 2018:839-860.
75. Silverman DT, Koutros S, Figueroa JD, Prokunina-Olsson L, Rothman N. Bladder cancer. In: Thun MJ, Linet MS, Cerhan JR, Haiman CA, Schottenfeld D, eds. Cancer Epidemiology and Prevention. 4th ed. New York: Oxford University Press; 2018:977-996.
76. Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC. Association between smoking and risk of bladder cancer among men and women. JAMA. 2011;306:737-745.
77. Islami F, Goding Sauer A, Miller KD, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin. 2018;68:31-54.
78. Ferlay J, Partensky C, Bray F. More deaths from pancreatic cancer than breast cancer in the EU by 2017. Acta Oncol. 2016;55:1158-1160.
79. Wilson LF, Antonsson A, Green AC, et al. How many cancer cases and deaths are potentially preventable? Estimates for Australia in 2013. Int J Cancer. 2018;142:691-701.
80. Brown KF, Rumgay H, Dunlop C, et al. The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015. Br J Cancer. 2018;118:1130-1141.
81. Pineros M, Znaor A, Mery L, Bray F. A global cancer surveillance framework within noncommunicable disease surveillance: making the case for population-based cancer registries. Epidemiol Rev. 2017;39:161-169.
82. Parkin DM. The role of cancer registries in cancer control. Int J Clin Oncol. 2008;13:102-111.
83. Bray F, Soerjomataram I, Mery L, Ferlay J. Improving the quality and coverage of cancer registries globally. Lancet 2015;386:1035-1036.